INGN Q4 2022 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$88M+15.3% YoY

Gross Profit

$29M33.5% margin

Operating Income

-$58M-66.4% margin

Net Income

-$57M-64.3% margin

EPS (Diluted)

$-2.47

QoQ Revenue Growth

-16.4%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$23M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$405M

Total Liabilities

$108M

Stockholders' Equity

$297M

Cash & Equivalents

$187M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$88M	$76M	+15.3%
Gross Profit	$29M	$39M	-23.6%
Operating Income	-$58M	-$7M	-776.5%
Net Income	-$57M	-$23M	-147.5%

Geographic Segments

UNITED STATES

$67M76%

Non-US

$21M24%